Bioscience Animal Health Public Company Limited (BIS) Stock Statistics & Valuation Metrics

Bioscience Animal Health Public Company Limited has a market cap or net worth of THB 715.92M. The enterprise value is THB 395.07M.

Market Cap

THB 715.92M

Enterprise Value

THB 395.07M

Bioscience Animal Health Public Company Limited has 314,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

314,000,000

Owned by Insiders

―

Owned by Institutions

―

Bioscience Animal Health Public Company Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 1.89%.

Return on Equity (ROE)

0.05

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

1.89%

Return on Capital Employed (ROCE)

0.02

Revenue Per Employee

18.78M

Profits Per Employee

320.61K

Employee Count

120

Asset Turnover

1.79

Inventory Turnover

7.98

The current PE Ratio of Bioscience Animal Health Public Company Limited is 20.09. Bioscience Animal Health Public Company Limited’s PEG ratio is -0.39.

PE Ratio

20.09

PS Ratio

0.32

PB Ratio

0.90

Price to FCF

9.24

Price to Operating Cash Flow

8.81

PEG Ratio

-0.39

In the last 12 months, Bioscience Animal Health Public Company Limited had revenue of 2.25B and earned 38.47M in profits. Earnings per share was 0.12.

Revenue

2.25B

Gross Profit

342.14M

Operating Income

19.87M

Pretax Income

55.05M

Net Income

38.47M

EBITDA

40.55M

Earnings Per Share (EPS)

0.12

In the last 12 months, operating cash flow was 81.27M and capital expenditures -3.81M, giving a free cash flow of 77.45M billion.

Operating Cash Flow

81.27M

Free Cash Flow

77.45M

Free Cash Flow per Share

0.25

Bioscience Animal Health Public Company Limited pays an annual dividend of ―, resulting in a dividend yield of 4.77%

Dividend Per Share

―

Dividend Yield

4.77%

Payout Ratio

N/A

Free Cash Flow Yield

10.82%

Earnings Yield

4.98%

Beta

0.67

52-Week Price Change

-0.87%

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

45.01

Average Volume (3m)

669.48K

Bioscience Animal Health Public Company Limited upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 11, 2026

Next Earnings Date

Nov 18, 2026

Ex-Dividend Date

―

Bioscience Animal Health Public Company Limited as a current ratio of 2.36, with Debt / Equity ratio of 0.79%

Current Ratio

2.36

Quick Ratio

1.82

Debt to Market Cap

0.00

Net Debt to EBITDA

-1.14

Interest Coverage Ratio

16.52

In the past 12 months, Bioscience Animal Health Public Company Limited has paid 12.29M in taxes.

Income Tax

12.29M

Effective Tax Rate

0.22

Bioscience Animal Health Public Company Limited EV to EBITDA ratio is 19.12, with an EV/FCF ratio of 8.66.

EV to Sales

0.30

EV to EBITDA

19.12

EV to Free Cash Flow

8.66

EV to Operating Cash Flow

8.25

Bioscience Animal Health Public Company Limited has THB 248.77M in cash and marketable securities with THB 7.13M in debt, giving a net cash position of THB 241.64M billion.

Cash & Marketable Securities

THB 248.77M

Total Debt

THB 7.13M

Net Cash

THB 241.64M

Net Cash Per Share

THB 0.77

Tangible Book Value Per Share

THB 2.54

Gross margin is 14.09%, with operating margin of 0.78%, and net profit margin of 1.60%.

Gross Margin

14.09%

Operating Margin

0.78%

Pretax Margin

2.26%

Net Profit Margin

1.60%

EBITDA Margin

1.58%

EBIT Margin

0.78%

The average price target for Bioscience Animal Health Public Company Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-2.44%

EPS Growth Forecast

-50.93%